- Report
- March 2024
- 182 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 185 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 95 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- October 2023
- 172 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- January 2024
- 157 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- August 2022
- 110 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- May 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- November 2023
- 78 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- May 2023
- 140 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Ventricular Drainage Device market within the context of Neurology Devices is a specialized segment of the medical device industry. It is composed of devices used to drain cerebrospinal fluid (CSF) from the ventricles of the brain. These devices are used to treat hydrocephalus, a condition in which CSF accumulates in the ventricles of the brain, causing increased intracranial pressure. Ventricular drainage devices are typically inserted through a burr hole in the skull and connected to a drainage system.
Ventricular drainage devices are used in a variety of neurological conditions, including hydrocephalus, brain tumors, and intracranial hemorrhage. They are also used to monitor intracranial pressure and to administer medications.
The Ventricular Drainage Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Medtronic, Stryker, Integra LifeSciences, and Codman Neuro. Show Less Read more